NovaBay Pharmaceuticals, Inc. (NBY) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|
| Cash from Operations | -1.8M | -2.99M | -1.32M | -857K | -2.06M | -1.51M | -1.98M | -428K | -363K | -1.84M | -1.19M | -1.21M | -1.69M | -1.7M | -2.06M | -4.32M | -1.47M | -1.99M | -1.42M | -1.45M |
| Operating CF Margin % | -345.49% | - | - | -37.12% | -84.43% | -63.13% | -75.22% | -11.48% | -11.15% | -52.15% | -50.75% | -33.19% | -44.15% | -46.4% | -78.24% | -163.5% | -64.81% | -93.16% | -78.53% | -76.54% |
| Operating CF Growth % | 12.66% | -97.43% | 33.1% | -100.23% | -467.77% | 17.8% | -66.72% | 64.6% | 78.51% | -8.48% | 42.29% | 72% | -15.05% | 14.49% | -44.96% | -198.82% | -7.15% | -90.87% | -64.05% | 13.73% |
| Net Income | -1.29M | -1.96M | -3.33M | -1.32M | -1.21M | -2.15M | -2.92M | -1.72M | -1.76M | -2.04M | -1.34M | -8.21M | -136K | -2.15M | -111K | -159K | -2.29M | -1.86M | -1.52M | -1.75M |
| Depreciation & Amortization | 73K | 38K | 55K | 95K | 9K | 92K | 96K | 95K | 51K | 51K | 13K | 123K | 119K | 120K | 121K | 87K | 13K | 11K | 9K | 11K |
| Stock-Based Compensation | 0 | 4K | 0 | 0 | 0 | 0 | 0 | 0 | 62K | 64K | 0 | 0 | 0 | 0 | 184K | 0 | 0 | 0 | 0 | 173K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -285K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -654K | 20K | 617K | 142K | 253K | 560K | 584K | 906K | 947K | 486K | 75K | 5.57M | -700K | 154K | -2.27M | -4.17M | 227K | 307K | 183K | -6K |
| Working Capital Changes | 74K | -1.09M | 1.33M | 229K | -1.11M | -18K | 266K | 290K | 619K | -408K | 70K | 1.3M | -972K | 182K | 24K | -80K | 581K | -446K | -93K | 131K |
| Change in Receivables | -368K | 0 | 0 | 315K | -157K | 0 | 243K | -67K | 1.71M | -788K | 250K | 160K | -1.03M | 1.2M | -632K | 189K | 389K | -194K | 68K | -91K |
| Change in Inventory | 467K | -467K | 0 | -355K | 227K | 1K | -8K | 357K | 167K | 137K | -80K | 631K | -267K | -16K | -565K | 118K | -287K | 168K | -242K | 177K |
| Change in Payables | 0 | -779K | 1.7M | 337K | -989K | -25K | 162K | 162K | -1.42M | 279K | -74K | 539K | 78K | -1.13M | 0 | -425K | 588K | -593K | 267K | -34K |
| Cash from Investing | 0 | 0 | 0 | 0 | -2K | 0 | -2K | -3K | -2K | -2K | -13K | 0 | -80K | -8K | -24K | -12M | -17K | -2K | -25K | -21K |
| Capital Expenditures | 0 | 0 | 0 | 0 | -2K | 0 | -2K | -3K | -2K | -2K | -13K | 0 | -80K | -8K | -24K | -8K | -17K | -2K | -25K | -21K |
| CapEx % of Revenue | - | - | - | - | 0.08% | - | 0.08% | 0.08% | 0.06% | 0.06% | 0.56% | - | 2.09% | 0.22% | 0.91% | 0.3% | 0.75% | 0.09% | 1.38% | 1.11% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -11.99M | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -1.32M | -174K | -1.71M | 385K | 2.09M | -377K | -597K | -320K | -577K | 2.51M | 0 | 3.04M | 1.7M | 0 | -105K | 14.79M | 219K | 1.77M | 0 | 5K |
| Debt Issued (Net) | 0 | 0 | -507K | 500K | -790K | -603K | -597K | -704K | 0 | 2.81M | 0 | 0 | 0 | 0 | -105K | 105K | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | -174K | -1000K | 0 | 1000K | 226K | 0 | 565K | 0 | 0 | 0 | 1000K | 1000K | 0 | 0 | 1000K | 219K | 1000K | 0 | 0 |
| Dividends Paid | -4.82M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | -174K | -1.81M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 3.5M | 0 | 0 | -115K | 0 | 0 | 0 | -181K | -577K | -294K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5K |
| Net Change in Cash | -3.12M | -3.12M | 8.17M | -346K | 25K | -1.07M | -1.1M | -548K | -942K | 668K | -1.62M | 1.49M | -63K | -1.71M | -2.19M | -1.52M | -1.27M | -214K | -1.44M | -1.46M |
| Free Cash Flow | -1.8M | -2.99M | -1.32M | -857K | -2.06M | -1.51M | -1.98M | -431K | -365K | -1.84M | -1.2M | -1.21M | -1.77M | -1.71M | -2.08M | -4.33M | -1.49M | -1.99M | -1.44M | -1.47M |
| FCF Margin % | -345.49% | - | - | -37.12% | -84.51% | -63.13% | -75.29% | -11.56% | -11.21% | -52.21% | -51.3% | -33.19% | -46.24% | -46.61% | -79.16% | -163.8% | -65.56% | -93.25% | -79.91% | -77.65% |
| FCF Growth % | 12.75% | -97.43% | 33.17% | -98.84% | -465.21% | 17.89% | -65.08% | 64.35% | 79.37% | -8.08% | 42.34% | 72.05% | -19.12% | 14.18% | -44.11% | -195.09% | -8% | -91.07% | -66.94% | 12.48% |
| FCF per Share | -0.31 | -0.51 | -0.24 | -0.18 | -0.56 | -1.31 | -2.81 | -2.19 | -2.72 | -20.27 | -20.64 | -22.35 | -38.60 | -39.65 | -50.90 | -116.95 | -40.50 | -57.25 | -42.34 | -42.99 |
| FCF Conversion (FCF/Net Income) | 1.39x | 1.56x | -0.17x | 0.71x | 1.70x | 0.96x | 0.62x | 0.10x | 0.21x | 0.91x | 0.68x | 0.15x | 12.42x | 0.79x | 18.53x | 27.33x | 0.64x | 1.07x | 0.93x | 0.82x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4K | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |